24 February 2021
Latham Advises the Underwriters in Adagene’s US IPO
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Cathy Yeung Lead | Latham & Watkins LLP | Partner | Not stated | Hong Kong |
| Benjamin Su Lead | Latham & Watkins LLP | Partner | Not stated | Hong Kong |
| Daying Zhang Lead | Latham & Watkins LLP | Partner | Not stated | Hong Kong |
| Michael Sullivan Lead | Latham & Watkins LLP | Partner | Not stated | San Diego |
| Chimmy Tao | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Jeffrey Woodley | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Samuel Weiner | Latham & Watkins LLP | Partner | tax | Los Angeles |
| Janet Hsu | Latham & Watkins LLP | Associate | tax | Orange County |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington D.C. |
| Barrett Tenbarge | Latham & Watkins LLP | Associate | FDA regulatory | Washington D.C. |
| Chris Hazuka | Latham & Watkins LLP | Partner | IP | San Diego |
| Robert Yeh | Latham & Watkins LLP | Associate | IP | San Diego |
Stated terms
- Stated value
- USD 140m (approximately US$140 million)
- What the figure measures
- Issue size
- Client
- Goldman Sachs, Morgan Stanley and JefferiesUnderwriters
- Counterparties
- Adagene Inc. (Issuer)